UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Arbidol as a broad-spectrum antiviral: An update

Antiviral research, 2014-07, Vol.107, p.84-94

2014

Volltextzugriff (PDF)

Circulating micro-RNAs as biomarkers of liver fibrosis progression in hepatitis C virus/HIV-1-co-infected patients: a ‘miR’-velous opportunity of early diagnosis?

AIDS (London), 2021-07, Vol.35 (9), p.1499-1500

Pécheur, Eve-Isabelle

2021

Volltextzugriff (PDF)

Hepatitis C Virus Hypervariable Region 1 Modulates Receptor Interactions, Conceals the CD81 Binding Site, and Protects Conserved Neutralizing Epitopes

Journal of Virology, 2010-06, Vol.84 (11), p.5751-5763

2010

Volltextzugriff (PDF)

The Synthetic Antiviral Drug Arbidol Inhibits Globally Prevalent Pathogenic Viruses

Journal of virology, 2016-01, Vol.90 (6), p.3086-3092

2016

Volltextzugriff (PDF)

Multiple effects of silymarin on the hepatitis C virus lifecycle

Hepatology (Baltimore, Md.), 2010-06, Vol.51 (6), p.1912-1921

2010

Volltextzugriff (PDF)

Characterization of Fusion Determinants Points to the Involvement of Three Discrete Regions of Both E1 and E2 Glycoproteins in the Membrane Fusion Process of Hepatitis C Virus

Journal of Virology, 2007-08, Vol.81 (16), p.8752-8765

2007

Volltextzugriff (PDF)

Heparanase-1 is upregulated by hepatitis C virus and favors its replication

Journal of hepatology, 2022-07, Vol.77 (1), p.29-41

2022

Volltextzugriff (PDF)

Hepatitis C virus infection propagates through interactions between Syndecan‐1 and CD81 and impacts the hepatocyte glycocalyx

Cellular microbiology, 2017-05, Vol.19 (5), p.e12711-n/a

2017

Volltextzugriff (PDF)

Molecular Crosstalk between the Hepatitis C Virus and the Extracellular Matrix in Liver Fibrogenesis and Early Carcinogenesis

Cancers, 2021-05, Vol.13 (9), p.2270

2021

Volltextzugriff (PDF)

Silibinin inhibits hepatitis C virus entry into hepatocytes by hindering clathrin‐dependent trafficking

Cellular microbiology, 2013-11, Vol.15 (11), p.1866-1882

2013

Volltextzugriff (PDF)

Low-density hepatitis C virus infectious particles are protected from oxidation by secreted cellular proteins

mBio, 2023-10, Vol.14 (5), p.e0154923-e0154923

2023

Volltextzugriff (PDF)

Curcumin against hepatitis C virus infection: spicing up antiviral therapies with ‘nutraceuticals’?

Gut, 2014-07, Vol.63 (7), p.1035-1037

Pecheur, Eve-Isabelle

2014

Volltextzugriff (PDF)

Targeting cell entry of enveloped viruses as an antiviral strategy

Molecules, 2010-12, Vol.16 (1), p.221-250

2010

Volltextzugriff (PDF)

Mechanism of inhibition of enveloped virus membrane fusion by the antiviral drug arbidol

PloS one, 2011-01, Vol.6 (1), p.e15874

2011

Volltextzugriff (PDF)

Hepatitis C Virus Envelope Glycoprotein E1 Forms Trimers at the Surface of the Virion

Journal of virology, 2015-10, Vol.89 (20), p.10333-10346

2015

Volltextzugriff (PDF)

First description of a compensatory xylosyltransferase I induction observed after an antifibrotic UDP-treatment of normal human dermal fibroblasts

Biochemical and biophysical research communications, 2019-04, Vol.512 (1), p.7-13

2019

Volltextzugriff (PDF)

Impact of Gold Nanoparticles on the Functions of Macrophages and Dendritic Cells

Cells (Basel, Switzerland), 2021-01, Vol.10 (1), p.96

2021

Volltextzugriff (PDF)

Very-Low-Density Lipoprotein (VLDL)-Producing and Hepatitis C Virus-Replicating HepG2 Cells Secrete No More Lipoviroparticles than VLDL-Deficient Huh7.5 Cells

Journal of Virology, 2013-05, Vol.87 (9), p.5065-5080

2013

Volltextzugriff (PDF)

Innovative particle standards and long-lived imaging for 2D and 3D dSTORM

Scientific reports, 2019-11, Vol.9 (1), p.17967-13, Article 17967

2019

Volltextzugriff (PDF)

Low pH-dependent Hepatitis C Virus Membrane Fusion Depends on E2 Integrity, Target Lipid Composition, and Density of Virus Particles

The Journal of biological chemistry, 2009-06, Vol.284 (26), p.17657-17667

2009

Volltextzugriff (PDF)

Altered BMP2/4 Signaling in Stem Cells and Their Niche: Different Cancers but Similar Mechanisms, the Example of Myeloid Leukemia and Breast Cancer

Frontiers in cell and developmental biology, 2022-01, Vol.9, p.787989

2022

Volltextzugriff (PDF)

Lipids ‒ A key for hepatitis C virus entry and a potential target for antiviral strategies

Biochimie, 2013-01, Vol.95 (1), p.96-102

2013

Volltextzugriff (PDF)

The hepatitis C virus and its hepatic environment: a toxic but finely tuned partnership

Biochemical journal, 2009-11, Vol.423 (3), p.303-314

2009

Volltextzugriff (PDF)

Arbidol inhibits viral entry by interfering with clathrin-dependent trafficking

Antiviral research, 2013-10, Vol.100 (1), p.215-219

2013

Volltextzugriff (PDF)

Glutathione peroxidase 4 is reversibly induced by HCV to control lipid peroxidation and to increase virion infectivity

Gut, 2016-01, Vol.65 (1), p.144-154

2016

Volltextzugriff (PDF)

1 – 25 von 98

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(95)
Mit Volltextzugriff
(89)

Publikationsform

Artikel
(96)
Buchkapitel
(2)

Sprache

Englisch
(92)
Französisch
(6)

Erscheinungsjahr

n.n

Thema

Science & Technology
(78)
Life Sciences & Biomedicine
(56)
Life Sciences
(50)
Humans
(47)
Hepatitis C Virus
(39)
Virology
(28)
Biochemistry, Molecular Biology
(23)
Science & Technology - Other Topics
(22)
Multidisciplinary Sciences
(21)
Biochemistry & Molecular Biology
(20)
Hepacivirus - Physiology
(19)
Viruses
(19)
Animals
(18)
Hepatitis
(18)
Infections
(17)
Hepatitis C
(16)
Biology And Life Sciences
(15)
Infectious Diseases
(14)
Membrane Fusion
(14)
Proteins
(14)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Arbidol as a broad-spectrum antiviral: An update

Circulating micro-RNAs as biomarkers of liver fibrosis progression in hepatitis C virus/HIV-1-co-infected patients: a ‘miR’-velous opportunity of early diagnosis?

Hepatitis C Virus Hypervariable Region 1 Modulates Receptor Interactions, Conceals the CD81 Binding Site, and Protects Conserved Neutralizing Epitopes

The Synthetic Antiviral Drug Arbidol Inhibits Globally Prevalent Pathogenic Viruses

Multiple effects of silymarin on the hepatitis C virus lifecycle

Characterization of Fusion Determinants Points to the Involvement of Three Discrete Regions of Both E1 and E2 Glycoproteins in the Membrane Fusion Process of Hepatitis C Virus

Heparanase-1 is upregulated by hepatitis C virus and favors its replication

Hepatitis C virus infection propagates through interactions between Syndecan‐1 and CD81 and impacts the hepatocyte glycocalyx

Molecular Crosstalk between the Hepatitis C Virus and the Extracellular Matrix in Liver Fibrogenesis and Early Carcinogenesis

Silibinin inhibits hepatitis C virus entry into hepatocytes by hindering clathrin‐dependent trafficking

Low-density hepatitis C virus infectious particles are protected from oxidation by secreted cellular proteins

Curcumin against hepatitis C virus infection: spicing up antiviral therapies with ‘nutraceuticals’?

Targeting cell entry of enveloped viruses as an antiviral strategy

Mechanism of inhibition of enveloped virus membrane fusion by the antiviral drug arbidol

Hepatitis C Virus Envelope Glycoprotein E1 Forms Trimers at the Surface of the Virion

First description of a compensatory xylosyltransferase I induction observed after an antifibrotic UDP-treatment of normal human dermal fibroblasts

Impact of Gold Nanoparticles on the Functions of Macrophages and Dendritic Cells

Very-Low-Density Lipoprotein (VLDL)-Producing and Hepatitis C Virus-Replicating HepG2 Cells Secrete No More Lipoviroparticles than VLDL-Deficient Huh7.5 Cells

Innovative particle standards and long-lived imaging for 2D and 3D dSTORM

Low pH-dependent Hepatitis C Virus Membrane Fusion Depends on E2 Integrity, Target Lipid Composition, and Density of Virus Particles

Altered BMP2/4 Signaling in Stem Cells and Their Niche: Different Cancers but Similar Mechanisms, the Example of Myeloid Leukemia and Breast Cancer

Lipids ‒ A key for hepatitis C virus entry and a potential target for antiviral strategies

The hepatitis C virus and its hepatic environment: a toxic but finely tuned partnership

Arbidol inhibits viral entry by interfering with clathrin-dependent trafficking

Glutathione peroxidase 4 is reversibly induced by HCV to control lipid peroxidation and to increase virion infectivity

Suchergebnisse filtern